An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis
Open Access
- 1 September 2014
- journal article
- research article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 13 (5) , 557-563
Abstract
No abstract availableKeywords
Funding Information
- University of Aberdeen Development TRUST
- Translational Medicine Research Collaboration (TMRC INF_AU_124)
This publication has 26 references indexed in Scilit:
- Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary diseaseThorax, 2012
- Serum levels of matrix metalloproteinase‐9, tissue inhibitors of metalloproteinase‐1 and their ratio are associated with impaired lung function in the elderly: A population‐based studyRespirology, 2010
- Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary diseaseRespiratory Medicine, 2009
- Protein Array Characterization of Bioactive Proteins Secreted By Immortalized Human Corneal Epithelium in Response to Pseudomonas ConstituentsCurrent Eye Research, 2009
- Peroxisome proliferator-activated receptor-γ in cystic fibrosis lung epitheliumAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Reference Ranges for Spirometry Across All AgesAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Airway remodelling in children with cystic fibrosisThorax, 2007
- Association between Pulmonary Function and Sputum Biomarkers in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Induced sputum matrix metalloproteinase‐9 correlates with lung function and airway inflammation in children with cystic fibrosisPediatric Pulmonology, 2005
- Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alphaThorax, 2002